-+ 0.00%
-+ 0.00%
-+ 0.00%

YD Bio files initial beneficial ownership statement; Chief Medical Officer and director Zhang Bo-Xiang reports 31,141 ordinary shares

Reuters·03/27/2026 20:05:37

Please log in to view news